Maravai Lifesciences Holdings (MRVI) Change in Account Payables (2020 - 2026)

Maravai Lifesciences Holdings' Change in Account Payables history runs 7 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 970.34% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at -$477000.0 (down 112.9% YoY), while the FY2025 annual figure was -$7.3 million, down 1116.18% from the prior year.
• Change in Account Payables for Q1 2026 stood at $6.2 million, up from -$5.5 million in the prior quarter.
• The five-year high for Change in Account Payables was $6.2 million in Q1 2026, with the low at -$5.5 million in Q4 2025.
• The 5-year median for Change in Account Payables is $1.7 million (2023), against an average of $190823.5.
• The sharpest annual moves came in 2024 and 2026: Change in Account Payables tumbled 1466.81% in 2024, then surged 970.34% in 2026.
• Maravai Lifesciences Holdings' Change in Account Payables stood at -$3.5 million in 2022, then surged by 147.84% to $1.7 million in 2023, then surged by 35.86% to $2.3 million in 2024, then tumbled by 344.68% to -$5.5 million in 2025, then jumped by 211.73% to $6.2 million in 2026.
• Business Quant data shows MRVI's Change in Account Payables at $6.2 million in Q1 2026, -$5.5 million in Q4 2025, and -$2.9 million in Q3 2025.